Prescription Opioid Study on Tapering (POST)
Principal Investigator: Rebecca Rossom, MD, MS
Study Sponsor: Food and Drug Administration
Purpose of study: In the past few years, many people have changed how they are taking opioids, and some people have reduced their dose or stopped taking opioid medications. We would like to learn what those experiences were like from people who went through them. We would like to hear about what worked well and what did not work well and how people felt during that time. Interested and eligible participants will complete a one-time, 60 minute telephone interview with a study team member.
Inclusion Criteria: Current HealthPartners member who has reduced or tapered opioid use, or in limited cases, a family member.
Study Contact:
Center for Evaluation & Survey Research
(833) 294-2994